the effects of chemotherapy with either chap-5 ( a drug regimen consisting of adriamycin , cis-dichlorodiammine platinum ( ii ) , hexamethylmelamine and cyclophosphamide ) or hexa caf ( a drug regimen consisting of methotrexate , 5-fluorouracil , hexamethylmelamine and cyclophosphamide ) on the immunocompetence of 22 patients with advanced ovarian carcinoma were studied .
C0062594
hexa caf
C0025677
methotrexate